Literature DB >> 28523358

FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET.

Eric Laffon1,2, Roger Marthan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28523358     DOI： 10.1007/s00259-017-3719-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  7 in total

1.  Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).

Authors:  Salvatore Annunziata; Annarosa Cuccaro; Maria Lucia Calcagni; Stefan Hohaus; Alessandro Giordano; Vittoria Rufini
Journal:  Ann Nucl Med       Date:  2016-05-31       Impact factor: 2.668

2.  Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan.

Authors:  Dirk Hasenclever; Lars Kurch; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11       Impact factor: 9.236

3.  Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology.

Authors:  Eric Laffon; Roger Marthan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-12       Impact factor: 9.236

4.  qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.

Authors:  Dirk Hasenclever; Lars Kurch; Christine Mauz-Körholz; Andreas Elsner; Thomas Georgi; Hamish Wallace; Judith Landman-Parker; Angelina Moryl-Bujakowska; Michaela Cepelová; Jonas Karlén; Ana Álvarez Fernández-Teijeiro; Andishe Attarbaschi; Alexander Fosså; Jane Pears; Andrea Hraskova; Eva Bergsträsser; Auke Beishuizen; Anne Uyttebroeck; Eckhard Schomerus; Osama Sabri; Dieter Körholz; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-07       Impact factor: 9.236

5.  Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

Authors:  Michel Meignan; Anne Ségolène Cottereau; Annibale Versari; Loïc Chartier; Jehan Dupuis; Sami Boussetta; Ilaria Grassi; René-Olivier Casasnovas; Corinne Haioun; Hervé Tilly; Vittoria Tarantino; Julien Dubreuil; Massimo Federico; Gilles Salles; Stefano Luminari; Judith Trotman
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

6.  Measurement uncertainty of lesion and reference mediastinum standardized uptake value in lung cancer.

Authors:  Eric Laffon; Noel Milpied; Roger Marthan
Journal:  Nucl Med Commun       Date:  2017-06       Impact factor: 1.690

Review 7.  FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Authors:  Sally F Barrington; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236
  7 in total
  1 in total

1.  Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET".

Authors:  Regine Kluge; Sally Barrington; Lars Kurch; Dirk Hasenclever
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-22       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.